CL2008000454A1 - Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica. - Google Patents

Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica.

Info

Publication number
CL2008000454A1
CL2008000454A1 CL200800454A CL2008000454A CL2008000454A1 CL 2008000454 A1 CL2008000454 A1 CL 2008000454A1 CL 200800454 A CL200800454 A CL 200800454A CL 2008000454 A CL2008000454 A CL 2008000454A CL 2008000454 A1 CL2008000454 A1 CL 2008000454A1
Authority
CL
Chile
Prior art keywords
granulum
nucleus
pharmaceutical composition
coating layer
quetiapine
Prior art date
Application number
CL200800454A
Other languages
English (en)
Inventor
Amenoz Anna Ubeda Perez C Ruiz
Original Assignee
Lesvi Laboratorios Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38089224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000454(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lesvi Laboratorios Sl filed Critical Lesvi Laboratorios Sl
Publication of CL2008000454A1 publication Critical patent/CL2008000454A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200800454A 2007-02-14 2008-02-13 Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica. CL2008000454A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07380037A EP1958617B1 (en) 2007-02-14 2007-02-14 Pharmaceutical compositions containing quetiapine fumarate

Publications (1)

Publication Number Publication Date
CL2008000454A1 true CL2008000454A1 (es) 2008-05-23

Family

ID=38089224

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200800454A CL2008000454A1 (es) 2007-02-14 2008-02-13 Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica.

Country Status (9)

Country Link
US (1) US20080193527A1 (es)
EP (1) EP1958617B1 (es)
AR (1) AR065342A1 (es)
AT (1) ATE480227T1 (es)
CL (1) CL2008000454A1 (es)
DE (1) DE602007009036D1 (es)
ES (2) ES2352299T3 (es)
PT (1) PT1958617E (es)
WO (1) WO2008098969A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
WO2011154118A1 (en) * 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
TR201104977A1 (tr) 2011-05-23 2012-12-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım gerçekleştiren kaplamaya sahip ketiapin formülasyonu.
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
WO2013100879A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical compositions comprising quetiapine
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
CN104523600A (zh) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 一种富马酸喹硫平缓释微丸及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
GB9611328D0 (en) 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
GB9716161D0 (en) 1997-08-01 1997-10-08 Zeneca Ltd Process
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
US20050003001A1 (en) 2001-11-07 2005-01-06 Hisami Yamaguchi Method for improving dissolution of poorly dispersible medicaments
AU2003235435A1 (en) 2002-03-20 2003-10-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of quetiapine hemifumarate
US7238686B2 (en) 2003-03-03 2007-07-03 Hetero Drugs Limited Polymorphs of quetiapine fumarate
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
JP2007509155A (ja) 2003-10-21 2007-04-12 アルファーマ インコーポレイテッド クエチアピンを含有する薬剤
US20060280795A1 (en) * 2005-06-08 2006-12-14 Dexcel Pharma Technologies, Ltd. Specific time-delayed burst profile delivery system
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye

Also Published As

Publication number Publication date
WO2008098969A1 (en) 2008-08-21
DE602007009036D1 (de) 2010-10-21
US20080193527A1 (en) 2008-08-14
EP1958617B1 (en) 2010-09-08
ES2352299T3 (es) 2011-02-17
ATE480227T1 (de) 2010-09-15
ES2315159A1 (es) 2009-03-16
PT1958617E (pt) 2010-10-28
EP1958617A1 (en) 2008-08-20
ES2315159B1 (es) 2009-12-22
AR065342A1 (es) 2009-06-03

Similar Documents

Publication Publication Date Title
CL2008000454A1 (es) Un granulo que comprende un nucleo que comprende quetiapina y un agente aglutinante y una capa de recubrimiento que comprende un agente lubricante; procedimiento de preparacion; y composicion farmaceutica.
BRPI0718782A2 (pt) Agente de benefício que contém partícula de liberação
IL219268A (en) Anti-b79cd antibody, immunosuppressant and pharmacological agent that includes and uses it
ZA200809998B (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
IL223477A (en) Pharmaceutical preparation containing modified enzyme uricase
BRPI0812337A2 (pt) Agente de benefício contendo partícula de liberação
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
CL2008000095A1 (es) Composicion de tableta en tableta que comprende una tableta central con estrogenos, un rellenador/diluyente, un rellenador/aglomerante, un componente polimerico y una capa de tableta exterior comprimida con agentes terapeuticos, un rellenador/diluyen
ZA200808530B (en) Pharmaceutical composition for external use
ZA200808531B (en) Pharmaceutical composition for external use
IL204442A (en) Inhibitors of atpase-0fif, medicinal preparations containing them and their use
GB0724187D0 (en) Aqueous curable resein composition and aqueous coating composition
BRPI0906576A2 (pt) Composição farmacêutica, kit, uso de um composto, e, agente terapêutico para câncer
BRPI0719398A2 (pt) Composição farmacêutica.
DE112007000840A5 (de) Mehrschichtiger, insbesondere zweischichtiger Kupplungsbelag sowie Verfahren zu dessen Herstellung
EP2075010A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING CYCLODEXTRIN / PACLITAXEL INCLUSION AND METHOD OF MANUFACTURE
DK200900115U1 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
SI2502996T1 (sl) Anti-fgf23 protitelo in farmacevtski sestavek, ki ga vsebuje
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
HK1127883A1 (en) Extract of herbal and the composition containing the same
WO2009149058A3 (en) Modified release niacin formulations
EP2070919A4 (en) SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
PL2168584T3 (pl) Kompozycja farmaceutyczna zawierająca kombinację triazolobenzodiazepiny i selektywnego inhibitora wychwytu zwrotnego serotoniny
BRPI0811629A2 (pt) Composição farmacêutica que compreende a combinação de um agente anti-inflamatório e um agente anticonvulsivo